MATRIX PHARMACEUTICALS ApS: Financial statements 2023
CVR: 29625867
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MATRIX PHARMACEUTICALS ApS (CVR 29625867) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 1,193,100 and a net result of DKK 544,125 compared with DKK 580,419 the year before. That is an increase of 2.3% compared with the year before. The profit margin was 45.6%. Equity in the 2023 report amounted to DKK -44,125.
- Revenue
- DKK 1,193,100
- Gross Profit
- DKK 1,193,100
- Profit/Loss
- DKK 544,125
- Equity
- DKK -44,125
- Total Assets
- DKK 91,020
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 1.2 mio. | 1.2 mio. | 544 t. | -44 t. | - |
| 2022 | 1.2 mio. | 1.2 mio. | 580 t. | -80 t. | - |
| 2021 | - | 843 t. | 776 t. | -678 t. | 1 |
| 2020 | - | 849 t. | 731 t. | -1.5 mio. | 1 |
| 2019 | - | 35 t. | -310 t. | -2.2 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
MATRIX PHARMACEUTICALS ApS has published its annual report for 2022. Revenue came to DKK 1,166,040, and the net result was DKK 580,419.
About MATRIX PHARMACEUTICALS ApS
MATRIX PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Karsten Høilund Skafte. The board consists of Karsten Høilund Skafte. The company is owned by Karsten Høilund Skafte and KHS HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported revenue of DKK 1,090,380 and a net result of DKK 589,123 compared with DKK 440,028 the year before. Equity in the 2025 report amounted to DKK 589,123.